封面
市場調查報告書
商品編碼
1616721

血壓計市場機會、成長動力、產業趨勢分析與預測 2024 - 2032

Sphygmomanometer Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年,全球血壓計市場價值 34 億美元,由於心臟病發病率上升、技術進步以及創新產品的不斷推出,預計 2024 年至 2032 年複合年成長率為 8.5%。隨著高血壓變得越來越普遍,對準確可靠的血壓監測設備的需求不斷成長。具有自動讀數和連接功能的數位血壓計等技術創新可增強使用者體驗和資料管理。此外,設計和功能的不斷改進使這些設備更易於使用和高效,進一步推動市場在臨床和家庭環境中的擴張。

血壓計產業根據產品、操作、配置、最終用途和地區進行分類。由於其方便用戶使用的設計和更高的準確性,數位血壓計細分市場到 2023 年將達到 20 億美元。數位設備提供自動讀數,消除了手動錯誤並提供更快的結果,這使得它們對醫療保健專業人員和家庭用戶特別有吸引力。記憶體儲存、藍牙連接和易於閱讀的顯示器等功能的便利性進一步推動了它們的採用。

隨著高血壓管理意識的增強,對數位血壓計的需求可能會繼續上升,鞏固其在市場上的主導地位。手動血壓計細分市場在 2023 年創造了 14 億美元的收入,主要歸功於其長期的可靠性和成本效益。手動設備在臨床環境中經常受到青睞,允許醫療保健專業人員透過聽診獲得精確的血壓讀數,確保準確性。它們廣泛應用於易於獲得培訓和專業知識的醫院和診所。

市場範圍
開始年份 2023年
預測年份 2024-2032
起始值 34億美元
預測值 72 億美元
複合年成長率 8.5%

此外,手動血壓計不需要電池或電力,使其成為各種環境下的實用選擇。可靠性和實用性的結合有助於鞏固他們在市場中的地位。北美血壓計市場在 2023 年達到 6.407 億美元,在高血壓盛行率高和心血管健康意識增強的推動下,2024 年至 2032 年將以 6.1% 的複合年成長率成長。該地區受益於先進的醫療基礎設施和廣泛的醫療技術,促進了數位和手動血壓計的採用。由於專注於創新和優質醫療保健,北美將成為血壓計行業整體成長的關鍵貢獻者。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 包括高血壓在內的心血管疾病發生率上升
      • 醫療機構平均患者就診次數增加
      • 血壓計的技術進步
      • 不斷成長的老年人口池
    • 產業陷阱與挑戰
      • 嚴格的法規核准和合規性
  • 成長潛力分析
  • 監管環境
  • 2023 年定價分析
  • 技術景觀
  • 波特的分析
  • PESTEL分析
  • 未來市場趨勢
  • 差距分析

第 4 章:競爭格局

  • 介紹
  • 公司矩陣分析
  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章:市場估計與預測:按產品分類,2021 - 2032 年

  • 主要趨勢
  • 數位血壓計
    • 手臂式電子血壓計
    • 腕式電子血壓計
  • 無液體血壓計
  • 水銀血壓計

第 6 章:市場估計與預測:按營運情況,2021 - 2032 年

  • 主要趨勢
  • 手動的
  • 自動的
  • 半自動

第 7 章:市場估計與預測:按配置,2021 - 2032 年

  • 主要趨勢
  • 便攜的
  • 桌面安裝式
  • 落地式
  • 壁掛式

第 8 章:市場估計與預測:按最終用途,2021 - 2032 年

  • 主要趨勢
  • 醫院
  • 居家護理
  • 門診手術中心
  • 其他最終用戶

第 9 章:市場估計與預測:按地區分類,2021 - 2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章:公司簡介

  • A&D Company, Limited
  • ACCOSON
  • American Diagnostic Corporation
  • Beurer GmbH
  • Bosch + Sohn GmbH & Co. KG
  • BPL Medical Technologies Pvt. Ltd.
  • GE Healthcare
  • Little Doctor International (S) Pte. Ltd.
  • Microlife Corporation
  • Omron Healthcare, Inc.
  • Prestige Medical
  • Rudolf Riester GmbH
  • Rossmax International Ltd.
  • Spengler SAS
  • SunTech Medical, Inc.
簡介目錄
Product Code: 3651

The Global Sphygmomanometer Market was worth USD 3.4 billion in 2023 and is anticipated to exhibit an 8.5% CAGR from 2024 to 2032, attributed to the rising incidence of cardiac conditions, advancements in technology, and the ongoing launch of innovative products. As hypertension becomes increasingly common, there is a growing demand for accurate and reliable blood pressure monitoring devices. Technological innovations, such as digital sphygmomanometers with automated readings and connectivity features, enhance user experience and data management. Also, ongoing improvements in design and functionality are making these devices more accessible and efficient, further propelling the market's expansion in both clinical and home settings.

The sphygmomanometer industry is segregated based on product, operation, configuration, end-use, and region. The digital sphygmomanometer segment achieved USD 2 billion in 2023, owing to its user-friendly design and enhanced accuracy. Digital devices offer automatic readings, which eliminate manual errors and provide quicker results, making them particularly appealing for both healthcare professionals and home users. The convenience of features such as memory storage, Bluetooth connectivity, and easy-to-read displays further drives their adoption.

As awareness of hypertension management grows, the demand for digital sphygmomanometers is likely to continue rising, solidifying their dominance in the market. The manual sphygmomanometer segment generated USD 1.4 billion in 2023, primarily due to its longstanding reliability and cost-effectiveness. Often favored in clinical settings, manual devices allow healthcare professionals to take precise blood pressure readings through auscultation, ensuring accuracy. They are widely used in hospitals and clinics where training and expertise are readily available.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$3.4 Billion
Forecast Value$7.2 Billion
CAGR8.5%

Besides, manual sphygmomanometers do not require batteries or electricity, making them a practical choice in various environments. This combination of reliability and practicality helps reinforce their position in the market. North America sphygmomanometer market witnessed USD 640.7 million in 2023 and will grow at a 6.1% CAGR between 2024 and 2032, driven by a high prevalence of hypertension and increased awareness of cardiovascular health. The region benefits from advanced healthcare infrastructure and widespread access to medical technologies, facilitating the adoption of both digital and manual sphygmomanometers.Furthermore, ongoing initiatives to improve chronic disease management and promote preventive healthcare are further boosting demand. With a focus on innovation and quality healthcare, North America will stand as a key contributor to the overall growth of the sphygmomanometer industry.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of cardiovascular disorders including hypertension
      • 3.2.1.2 Increase in average patient visits in healthcare settings
      • 3.2.1.3 Technological advancements in sphygmomanometers
      • 3.2.1.4 Growing geriatric population pool
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Stringent regulatory approvals and compliance
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Pricing analysis, 2023
  • 3.6 Technology landscape
  • 3.7 Porter's analysis
  • 3.8 PESTEL analysis
  • 3.9 Future market trends
  • 3.10 Gap analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn and Units)

  • 5.1 Key trends
  • 5.2 Digital sphygmomanometer
    • 5.2.1 Arm electronic sphygmomanometer
    • 5.2.2 Wrist electronic sphygmomanometer
  • 5.3 Aneroid sphygmomanometer
  • 5.4 Mercury sphygmomanometer

Chapter 6 Market Estimates and Forecast, By Operation, 2021 - 2032 ($ Mn and Units)

  • 6.1 Key trends
  • 6.2 Manual
  • 6.3 Automatic
  • 6.4 Semi-automatic

Chapter 7 Market Estimates and Forecast, By Configuration, 2021 - 2032 ($ Mn and Units)

  • 7.1 Key trends
  • 7.2 Portable
  • 7.3 Desk mounted
  • 7.4 Floor standing
  • 7.5 Wall mounted

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn and Units)

  • 8.1 Key trends
  • 8.2 Hospitals
  • 8.3 Homecare
  • 8.4 Ambulatory surgical centers
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn and Units)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 A&D Company, Limited
  • 10.2 ACCOSON
  • 10.3 American Diagnostic Corporation
  • 10.4 Beurer GmbH
  • 10.5 Bosch + Sohn GmbH & Co. KG
  • 10.6 BPL Medical Technologies Pvt. Ltd.
  • 10.7 GE Healthcare
  • 10.8 Little Doctor International (S) Pte. Ltd.
  • 10.9 Microlife Corporation
  • 10.10 Omron Healthcare, Inc.
  • 10.11 Prestige Medical
  • 10.12 Rudolf Riester GmbH
  • 10.13 Rossmax International Ltd.
  • 10.14 Spengler SAS
  • 10.15 SunTech Medical, Inc.